Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Publications
2 shownTumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma
Such an indicator would be useful in selection of those node-negative patients with breast carcinoma who are at high risk for having occult metastasis at presentation. These pat...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,436
- Institution
- Lawrence Livermore National Laboratory
External Links
Identifiers
- ORCID
- 0000-0002-5860-0127
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.